Navigation Links
Innovive Pharmaceuticals Announces Data from Oncology Drug Programs,to be Presented at American Association for Cancer Research Annual,Meeting

------------------------------------- Abstract Number: 5587 ----------------------- ---------------------------------------------- Session: Poster Section 28, Experimental and Molecular Therapeutics 46, Poster Board #10 ----------------------- ---------------------------------------------- Session Date and Time: Wednesday, April 18, 2007, 8:00 a.m. - 12:00 p.m. ----------------------- ---------------------------------------------- Location: Exhibit Hall, Los Angeles Convention Center ----------------------- ----------------------------------------------

About INNO-406

INNO-406 (formerly known as NS-187) is an orally bioavailable, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor currently in Phase I clinical studies. According to a study published in the journal Blood (Dec. 1, 2005), INNO-406 is 25 to 55 times more potent than imatinib in vitro, and at least 10 times as effective as imatinib mesylate in suppressing the growth of Bcr-Abl bearing tumors. INNO-406 has demonstrated activity in 12 of 13 imatinib-resistant cell lines. In addition to its Bcr-Abl inhibitory properties, INNO-406 inhibits Lyn kinase. Upregulation of Lyn kinase activity is a well recognized cause of imatinib resistance. Lyn kinase activation has also been documented in a variety of solid tumors, including prostate cancer.

About INNO-206

INNO-206 (formerly DOXO-EMCH) is a doxorubicin prodrug designed to preferentially reach the tumor and reduce adverse events compared to native doxorubicin. A Phase I study of INNO-206 that demonstrated safety and objective clinical responses in a variety of tumor types was completed in 2005 and presented at the March 2006 Krebskongress meeting in Berlin. In this study, doses were administered at up to six times the standard dosing of doxorubicin without an increase in obser
'"/>




Page: 1 2 3

Related medicine technology :

1. Innovive Pharmaceuticals to Present Interim Data from Phase I Study of INNO-406 at the American Society of Clinical Oncology Annual Meeting
2. Innovive Pharmaceuticals Announces Preclinical Data from INNO-206 Oncology Program
3. Innovive Pharmaceuticals Announces Additional Data Presentations at American Association for Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:9/29/2014)... -- Repeated exposure to broad-spectrum antibiotics in the first two ... say researchers from The Children,s Hospital of ... data from electronic health records from the extensive CHOP ... children with four or more exposures to broad spectrum ... at risk for obesity. The study, published online September ...
(Date:9/29/2014)... Pharmacists have an important role in ... good clinical trials practices. The Hematology/Oncology Pharmacy Association ... Practice Standards, the first of its kind that ... pharmacists and institutions that conduct clinical trials. The ... the critical role of the pharmacist in the ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 ... market data on the EU5 Capsule Endoscopy Systems market. ... volume (in units) and average prices (in US dollars) ... Recorders and Capsule Endoscopy Workstations. The report ...
Breaking Medicine Technology:Antibiotic Use by Age 2 Associated with Obesity Risk 2Antibiotic Use by Age 2 Associated with Obesity Risk 3HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3
... and Company (NYSE: LLY ) announced the ... Committee voted today to recommend non-approval of liprotamase, a ... review for the treatment of exocrine pancreatic insufficiency (EPI). ... questions about the degree of efficacy of liprotamase and ...
... gloStream, maker of gloEMR and gloPM – the only ... software with Microsoft Office built right in – today announced ... the gloEMR product line. Like its predecessor versions, gloEMR 6.0 ... platform, SQL Server and Microsoft Office so users have access ...
Cached Medicine Technology:Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency 2gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0 2gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0 3
(Date:9/30/2014)... California (PRWEB) September 30, 2014 The ... to reach USD 38.75 billion by 2020 at an ... to a new study by Grand View Research, Inc. ... due to lifestyle habits such as excessive alcohol consumption ... organ failure rates is expected to serve this market ...
(Date:9/30/2014)... AxoGen, Inc. (NASDAQ: AXGN), a ... repair market, announced the presentation of clinical data for ... Surgery of the Hand (ASSH) 2014 Annual Meeting which ... , The ASSH Best Paper Award was given to ... for Large Gap Nerve Discontinuities: Outcomes From a National ...
(Date:9/30/2014)... World of Children Award ( http://www.worldofchildren.org ... nonprofit, Friends Without A Border (FWAB) – in New ... hospital in Cambodia that has become the nation’s model ... Cambodia’s appalling lack of pediatric healthcare when he met ... during a photography trip in 1993. , Horrified, Izu ...
(Date:9/30/2014)... Farmington, NY (PRWEB) September 30, 2014 Timber ... design/build process for the Olsen family’s reclaimed Douglas fir ... will cover the home’s journey from architectural planning, to the ... Dee Olsen turned to New Energy Works, after following the ... to design and build their dream vacation home on land ...
(Date:9/30/2014)... Minneapolis, MN (PRWEB) September 30, 2014 ... recognized leader in business technology and services was ... in First Call Effectiveness (FCE) in 2013. This ... devices properly the first time and for an ... longevity. For more than 20 years BEI Services ...
Breaking Medicine News(10 mins):Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 2Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 3Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 4Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 5Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 6Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Nobel Prize For Child Advocates Announces 2014 Health Award Honoree 2Health News:Nobel Prize For Child Advocates Announces 2014 Health Award Honoree 3Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 2Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 3Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3
... suffers collateral damage from blood sugar disease , , FRIDAY, ... cause of heart disease, stroke, blindness, kidney failure and ... quicker than they normally do with age, a new ... in lung function as they grow older, research published ...
... reported study concluded that errant electronic noise from iPods ... didnt sound right to the cardiac electrophysiologists at Childrens ... young adults with heart conditions requiring pacemakers. Many of ... players, and weve never seen any problem, says Charles ...
... G.,Rendell today released the text of his March 27 ... MCare fund assessment payments:, Dear Health Care Provider:, ... state was in a unique,position to extend MCare abatements ... health care for hundreds of thousands of uninsured,Pennsylvanians., ...
... at Catholic Facilities Join Union, LOS ANGELES, ... overwhelming majority of healthcare workers at St. Francis ... Foundation health clinics in,the Sacramento area voted in ... (UHW)., "This victory shows we,re united," said ...
... blood cells could warn doctors early to change treatments ... Temple University think they may have found a blood ... causes AIDS. , The researchers found an increase in ... of human immunodeficiency virus (HIV), according to a study ...
... Health Volunteers,Overseas (HVO) and the American Society of ... the first HVO hematology training program, at,Mulago Hospital ... 1500-bed,facility that serves as Uganda,s national referral, teaching, ... The overall goal of,this program is to improve ...
Cached Medicine News:Health News:Lung Capacity Declines Faster With Diabetes 2Health News:Lung Capacity Declines Faster With Diabetes 3Health News:iPods and similar devices found not to affect pacemaker function 2Health News:Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline 2Health News:Healthcare Workers Across California Vote to Join UHW 2Health News:Biomarker May Signal HIV Progression 2Health News:HVO Launches Hematology Program in Uganda in Partnership with ASH 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: